用溴隐亭对溢乳症和性腺功能减退进行长期治疗。
Long-term treatment of galactorrhoea and hypogonadism with bromocriptine.
作者信息
Thorner M O, McNeilly A S, Hagan C, Besser G M
出版信息
Br Med J. 1974 May 25;2(5916):419-22. doi: 10.1136/bmj.2.5916.419.
Abstract
Seventeen women and four men with galactorrhoea and associated hypogonadism have been treated with bromocriptine for 2 to 28 months. In 18 patients the gonadal status became normal as the galactorrhoea improved. The gonadally unresponsive patients had either pituitary tumours or premature menopause. Prolactin levels fell with treatment; withdrawal of the drug was associated with an increase in serum prolactin and a recurrence of the galactorrhoea and hypogonadism. Two patients tried to become pregnant on treatment and both succeeded. Raised prolactin levels appear to block the actions of the gonadotrophins at a gonadal level rather than prevent their synthesis or release; lowering prolactin secretion with bromocriptine allows resumption of normal gonadal function. Bromocriptine appears to be the treatment of choice for inappropriate lactation in association with hypogonadism on a long-term basis.
摘要
17名患有溢乳症及相关性腺功能减退的女性和4名男性接受了溴隐亭治疗，疗程为2至28个月。18例患者的性腺状况随着溢乳症的改善而恢复正常。性腺无反应的患者患有垂体肿瘤或过早绝经。治疗后催乳素水平下降；停药后血清催乳素升高，溢乳症和性腺功能减退复发。两名患者在治疗期间尝试怀孕，均成功。升高的催乳素水平似乎在性腺水平阻断了促性腺激素的作用，而不是阻止其合成或释放；用溴隐亭降低催乳素分泌可使性腺功能恢复正常。长期来看，溴隐亭似乎是治疗伴有性腺功能减退的不适当泌乳的首选药物。
相似文献
1
Long-term treatment of galactorrhoea and hypogonadism with bromocriptine.用溴隐亭对溢乳症和性腺功能减退进行长期治疗。
Br Med J. 1974 May 25;2(5916):419-22. doi: 10.1136/bmj.2.5916.419.
2
Hypogonadism, galactorrhoea and hyper-prolactinaemia: Evaluation of pituitary gonadotrophins reserve before and under bromocriptine.性腺功能减退、溢乳与高泌乳素血症：溴隐亭治疗前后垂体促性腺激素储备的评估
Acta Endocrinol (Copenh). 1977 Apr;84(4):738-49. doi: 10.1530/acta.0.0840738.
3
Clinical and hormonal response to bromocriptin (CB-154) in the galactorrhea syndromes.溴隐亭（CB - 154）对溢乳综合征的临床及激素反应
J Clin Endocrinol Metab. 1974 Jul;39(1):18-26. doi: 10.1210/jcem-39-1-18.
4
Effect of CB-154 (2 Br-a-ergocryptine) on serum follicle stimulating hormone, luteinzing hormone and prolactin in women with the amenorrhoea-galactorrhoea syndrome.CB - 154（2 - 溴 - α - 麦角隐亭）对闭经 - 溢乳综合征女性血清促卵泡激素、促黄体生成素及催乳素的影响
Acta Endocrinol (Copenh). 1975 May;79(1):25-33. doi: 10.1530/acta.0.0790025.
5
Bromocriptine treatment of hyperprolactinaemic hypogonadism.溴隐亭治疗高泌乳素血症性性腺功能减退症
Acta Endocrinol Suppl (Copenh). 1978;216:131-46.
6
7
Treatment of amenorrhoea, galactorrhoea and hypogonadism with bromocriptine.用溴隐亭治疗闭经、溢乳和性腺功能减退。
Aust N Z J Med. 1978 Jun;8(3):262-6. doi: 10.1111/j.1445-5994.1978.tb04521.x.
8
9
Galactorrhoea: successful treatment with reduction of plasma prolactin levels by brom-ergocryptine.溢乳症：用溴隐亭成功治疗，血浆催乳素水平降低。
Br Med J. 1972 Sep 16;3(5828):669-72. doi: 10.1136/bmj.3.5828.669.
10
Brom-ergocryptine in the treatment of phenothiazine-induced galactorrhoea.
Br J Psychiatry. 1975 Mar;126:285-8. doi: 10.1192/bjp.126.3.285.
引用本文的文献
1
Treatment of Prolactinoma.催乳素瘤的治疗。
Medicina (Kaunas). 2022 Aug 13;58(8):1095. doi: 10.3390/medicina58081095.
2
Changes in the Options for Management of Prolactin Secreting Pituitary Adenomas.催乳素分泌型垂体腺瘤治疗选择的变化
J Neurol Surg B Skull Base. 2021 Feb 18;83(Suppl 2):e49-e53. doi: 10.1055/s-0040-1722665. eCollection 2022 Jun.
3
Endocrinopathies and Male Infertility.内分泌疾病与男性不育症
Life (Basel). 2021 Dec 22;12(1):10. doi: 10.3390/life12010010.
4
Prolactinomas in males: any differences?男性泌乳素瘤：有何不同？
Pituitary. 2020 Feb;23(1):52-57. doi: 10.1007/s11102-019-01009-y.
5
PCOS and Hyperprolactinemia: what do we know in 2019?多囊卵巢综合征与高催乳素血症：2019年我们了解了什么？
Clin Med Insights Reprod Health. 2019 Sep 9;13:1179558119871921. doi: 10.1177/1179558119871921. eCollection 2019.
6
Cabergoline for the treatment of bromocriptine-resistant invasive giant prolactinomas.卡麦角林治疗溴隐亭抵抗型侵袭性巨大泌乳素瘤。
Endocrine. 2018 Nov;62(2):464-469. doi: 10.1007/s12020-018-1702-5. Epub 2018 Sep 20.
7
Higher TSH Levels Within the Normal Range Are Associated With Unexplained Infertility.促甲状腺激素（TSH）水平处于正常范围内偏高与不明原因不孕有关。
J Clin Endocrinol Metab. 2018 Feb 1;103(2):632-639. doi: 10.1210/jc.2017-02120.
8
Repositioning of bromocriptine for treatment of acute myeloid leukemia.溴隐亭重新定位用于治疗急性髓系白血病。
J Transl Med. 2016 Sep 7;14(1):261. doi: 10.1186/s12967-016-1007-5.
9
Characteristics of dynamic magnetic resonance image enhancement in prolactinomas resistant to dopamine agonist therapy.多巴胺激动剂治疗抵抗的催乳素瘤的动态磁共振成像增强特征
J Investig Med. 2015 Mar;63(3):529-33. doi: 10.1097/JIM.0000000000000138.
10
The cardiovascular effects of bromocriptine in Parkinsonism.溴隐亭治疗帕金森病的心血管作用。
Br J Clin Pharmacol. 1976 Aug;3(4):571-4. doi: 10.1111/j.1365-2125.1976.tb04877.x.
本文引用的文献
1
A simple fluorimetric method for the estimation of free 11-hydroxycorticoids in human plasma.一种用于测定人血浆中游离11-羟基皮质类固醇的简易荧光法。
J Clin Pathol. 1962 Jul;15(4):374-9. doi: 10.1136/jcp.15.4.374.
2
Prolactin: evidence that it is separate from growth hormone in human blood.
Science. 1970 Nov 13;170(3959):745-7. doi: 10.1126/science.170.3959.745.
3
A radioimmunoassay for human prolactin.一种用于检测人催乳素的放射免疫分析方法。
Proc Natl Acad Sci U S A. 1971 Aug;68(8):1902-6. doi: 10.1073/pnas.68.8.1902.
4
Levodopa suppression of prolactin in nonpuerperal galactorrhea.左旋多巴对非产褥期溢乳症患者催乳素的抑制作用
N Engl J Med. 1971 Nov 18;285(21):1160-3. doi: 10.1056/NEJM197111182852102.
5
Treatment of non-puerperal galactorrhoea with an ergot alkaloid.用麦角生物碱治疗非产褥期溢乳症。
Br Med J. 1971 Jul 24;3(5768):228-9. doi: 10.1136/bmj.3.5768.228.
6
Plasma prolactin activity in inappropriate lactation.非哺乳期的血浆催乳素活性。
Br Med J. 1971 Jul 24;3(5768):225-7. doi: 10.1136/bmj.3.5768.225.
7
A new approach to the inhibition of puerperal lactation.
J Obstet Gynaecol Br Commonw. 1973 Nov;80(11):945-51. doi: 10.1111/j.1471-0528.1973.tb02954.x.
8
Effect of anti-estrogenic action of clomiphene during the menstrual cycle: evidence for a change in the feedback sensitivity.克罗米芬在月经周期中的抗雌激素作用效果：反馈敏感性变化的证据。
J Clin Endocrinol Metab. 1973 Sep;37(3):356-65. doi: 10.1210/jcem-37-3-356.
9
Pituitary-ovarian interrelationships during the puerperium.
Am J Obstet Gynecol. 1972 Nov 1;114(5):589-94. doi: 10.1016/0002-9378(72)90833-2.
10
Functional evaluation of pituitary reserve in patients with the amenorrhea-galactorrhea syndrome utilizing luteinizing hormone-releasing hormone (LH-RH), L-dopa and chlorpromazine.利用促黄体生成激素释放激素（LH-RH）、左旋多巴和氯丙嗪对闭经-溢乳综合征患者垂体储备功能的评估
J Clin Endocrinol Metab. 1973 Dec;37(6):855-9. doi: 10.1210/jcem-37-6-855.
Zotero 插件